ORKA-001, targeting IL-23p19, Phase 1 trial ongoing, with pharmacokinetic (PK) data expected in 2H 2025ORKA-001 Phase 2a initiation expected in ...
Reported positive initial data from INSPIRE DUCHENNE trial of next-generation Duchenne gene therapy candidate, SGT-003; In mid-2025, ...
Archaeologists have uncovered a collection of bone tools in northern Tanzania that were shaped by ancient human ancestors 1 ...